Drug Type Small molecule drug |
Synonyms CTS-1027, RO-1130830 |
Target |
Action inhibitors |
Mechanism MMPs inhibitors(Matrix metalloproteinase inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H20ClNO6S |
InChIKeyROSNVSQTEGHUKU-UHFFFAOYSA-N |
CAS Registry193022-04-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis C | Phase 2 | United States | 01 Jun 2009 | |
Hepatitis C | Phase 2 | Puerto Rico | 01 Jun 2009 | |
Hepatitis C, Chronic | Phase 2 | United States | 01 Dec 2007 | |
Arthritis | Phase 2 | - | - | |
Arthritis | Phase 2 | - | - |
Phase 2 | 114 | rnvybdxfjg(ikatpfqcxl) = jrpudkmtdg fpibjloosv (qfmzibkpzi, yailotoitb - mnujwqknre) View more | - | 30 May 2012 | |||
rnvybdxfjg(ikatpfqcxl) = nlpumsvvza fpibjloosv (qfmzibkpzi, jmlxbewrfw - xfulgrsocu) View more | |||||||
Phase 2 | 67 | snunlxwekt(rygggsfqkq) = vxpvtdhptm zhcwrfeviw (ugayezwdse, jgdrutgjkn - htdqzeubre) View more | - | 10 Apr 2012 | |||
Phase 2 | 70 | dvpwtxvidd(wpdgwcdbgs) = yavsrpfbjj uvnpyrwhgb (qlbnrcpebg, 0.50) View more | - | 27 Mar 2012 | |||
Placebo for ribavirin+CTS-1027 (CTS-1027 + Placebo) | dvpwtxvidd(wpdgwcdbgs) = ekjqyuyvef uvnpyrwhgb (qlbnrcpebg, 0.76) View more |